Entelos, Inc. Granted Patent for Innovative Diagnostic Capability in Obesity, Diabetes
Published: Feb 03, 2010
FOSTER CITY, Calif.--(BUSINESS WIRE)--Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled “Apparatus and Methods for Assessing Metabolic Substrate Utilization” to the Company. These methods further strengthen the Entelos® Metabolism PhysioLab® platform and leverage insights about human physiology that can lead to improved diagnosis, clinical testing, and personalized treatment across a highly variable patient population. This method may also be used to improve the selection of patients for clinical trials of metabolic therapies and diagnostics.